UPDATE
1-Vitae-Boehringer diabetes drug fails as
add-on therapy in trial
June 29 (Reuters) - Vitae Pharmaceuticals Inc said its
drug to treat type 2
diabetes in overweight patients did **t meet its main goal in a mid-stage study testing it as an
add-on therapy.
